ClearMed
All AI in Medicine BriefingsThe Lancet Digital Health
AI in MedicineReal-World Cohort6 min read

Development and validation of early warning scores predicting 24 h mortality addressing intercurrent medical interventions in Denmark: a multicentre retrospective cohort study of 2·08 million hospital encounters

We aimed to compare the clinical net benefit of NEWS against simplified scoring rules and machine learning models, to determine whether simpler approaches suffice or if complex models offer meaningful advantages, and to evaluate performance heterogeneity across patient subgroups.

Published in The Lancet Digital HealthEHR Cohort study + Clinical AI evaluation
3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Source

Follow-Up Window

5 years

Model complexity produced small average clinical utility gains, concentrated among patients initially classified as high risk by NEWS.

What Changes?

AI in Medicine · Real-World Cohort

Current Standard

Conventional ai in medicine practice relies on standard-of-care monitoring and existing regimens prior to this ehr cohort study + clinical ai evaluation.

New Finding

These findings support prospective trials of risk-stratified monitoring based on the first NEWS assessment, testing simplified approaches for lower-risk patients while retaining full NEWS or electronic health record models for higher-risk patients.

3 Key Takeaways

Plain English Summary
  1. 01Core Finding

    In this multicentre retrospective cohort study, we included data from 15 Danish hospitals (ten hospital networks) across the Capital and Zealand regions of Denmark, between Oct 16, 2018, and Oct 16, 2023.

  2. 02Study Evidence

    Tested in a ehr cohort study + clinical ai evaluation (000 patients) at the real-world cohort stage.

  3. 03Practical Meaning

    AI model accuracy depends on training dataset diversity and requires prospective validation across independent hospitals before routine rollout.

What This Means for You

Model complexity produced small average clinical utility gains, concentrated among patients initially classified as high risk by NEWS. These findings support prospective trials of risk-stratified monitoring based on the first NEWS assessment, testing simplified approaches for lower-risk patients while retaining full NEWS or electronic health record models for higher-risk patients.

The Discovery

The National Early Warning Score (NEWS) is widely used to predict patient deterioration, but retrospective validations face intervention bias and emphasise discrimination performance over clinical utility. We aimed to compare the clinical net benefit of NEWS against simplified scoring rules and machine learning models, to determine whether simpler approaches suffice or if complex models offer meaningful advantages, and to evaluate performance heterogeneity across patient subgroups. In this multicentre retrospective cohort study, we included data from 15 Danish hospitals (ten hospital networks) across the Capital and Zealand regions of Denmark, between Oct 16, 2018, and Oct 16, 2023. We included all adults (aged ≥18 years) with a hospital encounter with at least one NEWS assessment. Demographic and clinical data, NEWS data, and time of death were extracted from hospital and regional electronic health records. Patients were followed up until death or completion of the 24 h observation period after the initial NEWS score was recorded, whichever occurred first. The outcome was all-cause mortality within 24 h of the initial NEWS recording. We compared NEWS against both simpler and more complex approaches for predicting 24 h mortality: simplified NEWS (NEWS without blood pressure and temperature), Demographic Early Warning Score (DEWS; simplified NEWS with age and sex), and a model based on Extreme Gradient Boosting Early Warning Score (XGB-EWS) incorporating vital signs, demographics, laboratory markers, plus medical history embeddings extracted using sentence transformers. We used propensity score weighting to mitigate intervention bias and evaluated performance using net benefit, area under the receiver operating characteristic curve, and calibration. This study included data for 2 080 765 hospital encounters representing 825 200 unique patients over 5 years. The majority (50·9%) of the weighted population was aged 18-65 years, 50·4% were female, 49·6% were male, and 66·2% were admitted to internal and acute medicine clinical specialties. Decision curve analysis in the overall population showed maximum net benefit differences of 1·9 additional correct mortality identifications per 10 000 patients between XGB-EWS and NEWS, and 1·5 per 10 000 patients between NEWS and simplified NEWS. However, stratified analyses revealed substantial heterogeneity: in the high-risk group (initial NEWS ≥7), XGB-EWS provided a maximum gain of 78·1 correct identifications per 10 000 patients compared with NEWS, whereas simplified NEWS resulted in a maximum performance loss of 60·2 per 10 000 patients. Conversely, in the low-risk group (NEWS 0-4), differences were minimal: XGB-EWS provided a maximum gain of 0·9 correct identifications per 10 000 patients compared with NEWS, while simplified NEWS resulted in a maximum loss of 0·1 per 10 000 patients.

How It Works, Simply

This ai in medicine research focuses on AI model. Researchers evaluated it using an eHR Cohort study + Clinical AI evaluation (000 patients) at the real-world cohort stage of medical research.

3 Key Takeaways

Clinical Takeaways
  1. 01Core Finding

    In this multicentre retrospective cohort study, we included data from 15 Danish hospitals (ten hospital networks) across the Capital and Zealand regions of Denmark, between Oct 16, 2018, and Oct 16, 2023.

  2. 02Study Evidence

    Tested in a ehr cohort study + clinical ai evaluation (000 patients) at the real-world cohort stage.

  3. 03Practical Meaning

    AI model accuracy depends on training dataset diversity and requires prospective validation across independent hospitals before routine rollout.

01

Biological Mechanism & Study Design

Study Design & Cohort

EHR Cohort study + Clinical AI evaluation

EHR Cohort study + Clinical AI evaluation (000 patients) · Real-World Cohort

Biological Pathway & Modality

AI model

Intervention: Development and validation of early warning scores predicting 24 h mortality

02

Experimental Findings & Endpoints

The National Early Warning Score (NEWS) is widely used to predict patient deterioration, but retrospective validations face intervention bias and emphasise discrimination performance over clinical utility.

We aimed to compare the clinical net benefit of NEWS against simplified scoring rules and machine learning models, to determine whether simpler approaches suffice or if complex models offer meaningful advantages, and to evaluate performance heterogeneity across patient subgroups. In this multicentre retrospective cohort study, we included data from 15 Danish hospitals (ten hospital networks) across the Capital and Zealand regions of Denmark, between Oct 16, 2018, and Oct 16, 2023.

We included all adults (aged ≥18 years) with a hospital encounter with at least one NEWS assessment. Demographic and clinical data, NEWS data, and time of death were extracted from hospital and regional electronic health records.

Patients were followed up until death or completion of the 24 h observation period after the initial NEWS score was recorded, whichever occurred first. The outcome was all-cause mortality within 24 h of the initial NEWS recording.

We compared NEWS against both simpler and more complex approaches for predicting 24 h mortality: simplified NEWS (NEWS without blood pressure and temperature), Demographic Early Warning Score (DEWS; simplified NEWS with age and sex), and a model based on Extreme Gradient Boosting Early Warning Score (XGB-EWS) incorporating vital signs, demographics, laboratory markers, plus medical history embeddings extracted using sentence transformers. We used propensity score weighting to mitigate intervention bias and evaluated performance using net benefit, area under the receiver operating characteristic curve, and calibration.

This study included data for 2 080 765 hospital encounters representing 825 200 unique patients over 5 years. The majority (50·9%) of the weighted population was aged 18-65 years, 50·4% were female, 49·6% were male, and 66·2% were admitted to internal and acute medicine clinical specialties.

Decision curve analysis in the overall population showed maximum net benefit differences of 1·9 additional correct mortality identifications per 10 000 patients between XGB-EWS and NEWS, and 1·5 per 10 000 patients between NEWS and simplified NEWS. However, stratified analyses revealed substantial heterogeneity: in the high-risk group (initial NEWS ≥7), XGB-EWS provided a maximum gain of 78·1 correct identifications per 10 000 patients compared with NEWS, whereas simplified NEWS resulted in a maximum performance loss of 60·2 per 10 000 patients.

Conversely, in the low-risk group (NEWS 0-4), differences were minimal: XGB-EWS provided a maximum gain of 0·9 correct identifications per 10 000 patients compared with NEWS, while simplified NEWS resulted in a maximum loss of 0·1 per 10 000 patients.

03

Clinical Translation & Practice Context

Model complexity produced small average clinical utility gains, concentrated among patients initially classified as high risk by NEWS.

These findings support prospective trials of risk-stratified monitoring based on the first NEWS assessment, testing simplified approaches for lower-risk patients while retaining full NEWS or electronic health record models for higher-risk patients.

03

The Bottom Line · Clinical Pearl

“Model complexity produced small average clinical utility gains, concentrated among patients initially classified as high risk by NEWS.”

Published in The Lancet Digital Health · Current Stage: Real-World Cohort

AI in Medicine · Real-World Cohort
Study Type
EHR Cohort study + Clinical AI evaluation

EHR Cohort study + Clinical AI evaluation (000 patients)

Evidence Score
3/5 · Real-World Observation
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Who It Applies To
EHR Cohort study + Clinical AI evaluation (000 patients) in ai in medicine care
Intervention & Mechanism
Development and validation of early warning scores predicting 24 h mortality

AI model

Key Limitation
AI model accuracy depends on training dataset diversity and requires prospective validation across independent hospitals before routine rollout.

Translational Stage

LEVEL 2 · Real-World Cohort

Classified as EHR Cohort study + Clinical AI evaluation along the clinical evidence continuum

  1. Lab & Discovery
  2. Early Trials
  3. Human Evidence
  4. 4Real-World CohortActive

Indexed Clinical Entities

Original Publication & AMA Citation

Development and validation of early warning scores predicting 24 h mortality addressing intercurrent medical interventions in Denmark: a multicentre retrospective cohort study of 2·08 million hospital encounters. The Lancet Digital Health. Published 2026;Nov 5. Accessed November 15, 2026. https://pubmed.ncbi.nlm.nih.gov/42988715/

The Lancet Digital Health

https://pubmed.ncbi.nlm.nih.gov/42988715/

Read Original Paper

Continue Reading

Related in AI in Medicine

View all AI in Medicine briefings →
AI in Medicine editorial photograph for ClinicalAge, a framework for modelling ageing trajectories from longitudinal electronic health records in the UK: a model development and validation study
AI IN MEDICINE · CLINICAL PRACTICE

ClinicalAge, a framework for modelling ageing trajectories from longitudinal electronic health records in the UK: a model development and validation study

Your Medical Records Could Reveal Your True 'Biological Age' — And Predict Your Health Future. A new AI tool, ClinicalAge, uses your existing health records to calculate your biological age, offering a powerful predictor of future health risks and lifespan.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readThe Lancet Digital Health
AI IN MEDICINE · CLINICAL PRACTICE

AI Enhances Bionic Vision Precision in Brain Implant Patient

An AI-powered system can precisely predict and generate personalized visual percepts in a blind individual with a brain implant by learning their unique cortical responses to electrical stimulation. Current bionic eye technologies, while offering some degree of visual perception, often struggle with precision, consistency, and the intuitive generation of meaningful visual information for the patient.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDaily
AI IN MEDICINE · PRECLINICAL

AI Discovers Natural Molecule for Obesity with Promising Side Effect Profile

AI-guided discovery of the natural molecule BRP offers a novel, potentially better-tolerated approach to obesity treatment than existing medications. BRP represents a potential 'Ozempic-like' treatment for obesity that may circumvent common digestive side effects and muscle loss often associated with current GLP-1 agonists.

2/5 Preclinical
Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readScienceDaily